| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $26,993,463 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL177653 | Pathogenicity and pathophysiology assessments of sarcomere gene variants identified in the clinic | 001 | 2 | NIH | 4/29/2026 | $18,254 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL177653 | Pathogenicity and pathophysiology assessments of sarcomere gene variants identified in the clinic | 000 | 2 | NIH | 2/18/2026 | $578,082 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS131327 | Role of CD8 T cell-mediated Pathology in Globoid Cell Leukodystrophy | 000 | 4 | NIH | 2/27/2026 | $504,601 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM128635 | Mechanisms of coordinate gene regulation by transcription factors | 001 | 8 | NIH | 3/11/2026 | $44,955 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM128635 | Mechanisms of coordinate gene regulation by transcription factors | 000 | 8 | NIH | 1/12/2026 | $404,595 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS125405 | Therapeutic implications of purinergic receptor P2X4 in ischemic stroke | 000 | 5 | NIH | 5/26/2026 | $416,250 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI167886 | Bacterial Reprogramming that Contributes to Antibiotic Persistence toward Topoisomerase Inhibitors | 000 | 3 | NIH | 3/30/2026 | $479,558 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | K01DK133627 | Examining the role of locus coeruleus glucagon-like peptide-1 receptors in feeding behavior | 001 | 4 | NIH | 1/16/2026 | $150,930 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081631 | CGRP-CLR mediated regulation of bone healing | 000 | 4 | NIH | 1/31/2026 | $392,876 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081631 | CGRP-CLR mediated regulation of bone healing | 001 | 4 | NIH | 5/14/2026 | $21,824 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01CA269147 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care | 002 | 5 | NIH | 5/7/2026 | $442,788 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | U01CA269147 | Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care | 003 | 5 | NIH | 5/22/2026 | $66,400 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 001 | 3 | NIH | 3/24/2026 | $16,015 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HL172239 | ASCVD risk assessment in T2DM facilitated by novel computational immunology programs | 000 | 3 | NIH | 2/12/2026 | $507,162 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR082440 | Causative mechanisms for keloid formation | 000 | 3 | NIH | 1/9/2026 | $392,705 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR082440 | Causative mechanisms for keloid formation | 001 | 3 | NIH | 5/14/2026 | $21,818 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AI173305 | Impact of Senolytics on Aged Vaccine Responses | 000 | 4 | NIH | 11/26/2025 | $416,250 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 001 | 4 | NIH | 4/16/2026 | $55,275 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA276286 | Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance | 000 | 4 | NIH | 2/13/2026 | $497,480 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | H5655627 | Grants to States for Loan Repayment | 00 | 1 | HRSA | 5/4/2026 | $218,112 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 000 | 3 | NIH | 1/20/2026 | $677,618 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084264 | Signaling mechanisms utilized by myostatin and related ligands in skeletal muscle | 001 | 3 | NIH | 5/14/2026 | $37,645 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R00AR078352 | Roles of the superficial zone in mature articular cartilage | 000 | 5 | NIH | 3/25/2026 | $224,101 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R00AR078352 | Roles of the superficial zone in mature articular cartilage | 001 | 5 | NIH | 5/14/2026 | $12,451 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR085652 | Engineered periarticular approach to manage osteoarthritic pain and improve joint health | 000 | 1 | NIH | 6/8/2026 | $658,289 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 Farmington Ave | Farmington | CT | 06030-5335 | CAPITOL | USA | R4354929 | Autism Secondary Data Analysis Program | 00 | 2 | HRSA | 6/2/2026 | $60,000 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 000 | 5 | NIH | 12/12/2025 | $387,625 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR077962 | MicroRNA regulation of osteoblast physiology and glucocorticoid signaling | 001 | 5 | NIH | 5/14/2026 | $21,535 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS124666 | Serine/Threonine Phosphatases in Neurological Diseases | 000 | 4 | NIH | 1/30/2026 | $454,846 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01NS133112 | Meningeal ectopic lymphoid tissues (mELTs): Composition, organization and expression revealed by imaging and in situ transcriptomics | 000 | 3 | NIH | 5/11/2026 | $517,092 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01HD112424 | Dysregulation of Endometrial Invasibility Proximal to Uterine Scar as a Mechanism of Placenta Accreta | 000 | 3 | NIH | 3/4/2026 | $479,620 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01GM144379 | The regulation of phosphoprotein phosphatases in the nucleus | 000 | 4 | NIH | 5/4/2026 | $362,972 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01DK134475 | Novel mechanisms of kidney inflammation and fibrosis | 000 | 4 | NIH | 12/17/2025 | $523,599 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21NS142499 | Transposon-mediated genetic manipulation of OPCs to study their role in synapse formation | 000 | 1 | NIH | 3/16/2026 | $471,861 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084284 | Cellular Therapy for Osteogenesis Imperfecta | 000 | 2 | NIH | 3/10/2026 | $341,258 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR084284 | Cellular Therapy for Osteogenesis Imperfecta | 001 | 2 | NIH | 5/14/2026 | $18,956 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR080131 | The role of Dot1L activity in chondrogenic differentiation | 000 | 5 | NIH | 3/31/2026 | $392,462 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR080131 | The role of Dot1L activity in chondrogenic differentiation | 001 | 5 | NIH | 5/14/2026 | $21,804 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081659 | Extracellular regulation of bone mass by transforming growth factor-ß-related ligands and their binding proteins | 000 | 5 | NIH | 3/25/2026 | $563,890 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AR081659 | Extracellular regulation of bone mass by transforming growth factor-ß-related ligands and their binding proteins | 001 | 5 | NIH | 5/14/2026 | $31,327 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM162319 | Investigating Dead Cell-Phagocyte Interaction at the Phagosomal Interface to Decode Death-Associated Responses | 000 | 1 | NIH | 3/18/2026 | $423,352 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R33CA309727 | Programmable Multiplexed Detection of Cell-free DNA Mutation for Liquid Biopsy | 000 | 1 | NIH | 5/7/2026 | $414,585 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R34DA065228 | Measurement-Based Care as an Implementation Strategy for Long-Acting Injectable Medications for Opioid Use Disorders in CCBHCs | 000 | 1 | NIH | 5/18/2026 | $172,075 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG058261 | Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration | 001 | 4 | NIH | 2/23/2026 | $70,313 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01AG058261 | Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration | 000 | 4 | NIH | 12/17/2025 | $632,825 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01EY038322 | Nfe2l3-regulated mechanisms of retinal ganglion cell neuroprotection and optic nerve axon regeneration | 000 | 1 | NIH | 4/10/2026 | $416,250 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R01CA303989 | A novel "cap-linker" strategy to target oncolytic viruses to the tumor | 000 | 1 | NIH | 5/19/2026 | $499,568 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R21AI195412 | HSV alkaline nuclease as a target for antiviral therapy | 000 | 1 | NIH | 4/21/2026 | $263,375 |
| | 2026 | 2026 | UNIVERSITY OF CONNECTICUT HEALTH CENTER | 263 FARMINGTON AVE | FARMINGTON | CT | 06030-0001 | CAPITOL | USA | R35GM162332 | Cracking the tubulin code of cell migration | 000 | 1 | NIH | 2/12/2026 | $457,875 |
|
